1 / 3
Mass Spect Gold Human Serum, Toxicology Negative, Lipid Free

MSG3200: Mass Spect Gold Human Serum, Toxicology Negative, Lipid Free

from $88.00

MSG3200 is a drug-free, lipid-depleted human serum matrix ideal for LC-MS/MS toxicology screening, method validation, and assay development. Extensively screened via LC/TOF-MS, GC-MS, LC-MS/MS, and EIA, this matrix is verified negative for over 300 drugs, metabolites, and interfering substances, including opiates, cannabinoids, amphetamines, and benzodiazepines.

Key Features:

  • Fully toxicology-negative human serum

  • Lipid-free: cholesterol ≤10 mg/dL, triglycerides ≤10 mg/dL

  • Drug-free verified by LC-MS/MS, GCMS, and EIA panels

  • Filtered to 0.1 µm, preservative-free, and tested pathogen-free

  • Designed for clinical mass spectrometry and research use

Applications:
Toxicology assay development, blank matrix for forensic LC-MS/MS workflows, negative control samples, and interference-free method validation.

Request a quote or general inquiry for bulk pricing, COA, or specification sheet.

Volume:

MSG3200 is a drug-free, lipid-depleted human serum matrix ideal for LC-MS/MS toxicology screening, method validation, and assay development. Extensively screened via LC/TOF-MS, GC-MS, LC-MS/MS, and EIA, this matrix is verified negative for over 300 drugs, metabolites, and interfering substances, including opiates, cannabinoids, amphetamines, and benzodiazepines.

Key Features:

  • Fully toxicology-negative human serum

  • Lipid-free: cholesterol ≤10 mg/dL, triglycerides ≤10 mg/dL

  • Drug-free verified by LC-MS/MS, GCMS, and EIA panels

  • Filtered to 0.1 µm, preservative-free, and tested pathogen-free

  • Designed for clinical mass spectrometry and research use

Applications:
Toxicology assay development, blank matrix for forensic LC-MS/MS workflows, negative control samples, and interference-free method validation.

Request a quote or general inquiry for bulk pricing, COA, or specification sheet.

 
MSG3200: Mass Spect Gold Human Serum, Toxicology Negative, Lipid Free
Download Spec Sheet

  • The research investigates the effects of the synthetic cannabinoid H4CBD on blood glucose response in a rat model with advanced metabolic syndrome. Despite not significantly altering fasting blood glucose or plasma insulin levels, H4CBD administration resulted in a noteworthy reduction in body mass, improvement in glucose response, and enhancement in insulin resistance markers.

    The study utilized Mass Spec Gold human serum (Golden West Diagnostics, MSG3200) to establish the bioavailability of H4CBD in plasma, ensuring precise measurements for the study's pharmacokinetic analysis.

    For a detailed look at the study's findings and the specific use of MSG3200 serum, you can read the full article at American Journal of Physiology.